Theratechnologies Inc TQ8-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 9:07 AM CET
0.85quote price arrow up+0.015 (+1.80%)
52 week range
0.75 - 2.80
Loading...
  • Open0.85
  • Day High0.85
  • Day Low0.85
  • Prev Close1.05
  • 52 Week High2.80
  • 52 Week High Date02/02/22
  • 52 Week Low0.75
  • 52 Week Low Date12/20/22

Key Stats

  • Market Cap88.44M
  • Shares Out95.14M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change1.8

KEY STATS

  • Open0.85
  • Day High0.85
  • Day Low0.85
  • Prev Close1.05
  • 52 Week High2.80
  • 52 Week High Date02/02/22
  • 52 Week Low0.75
  • 52 Week Low Date12/20/22
  • Market Cap88.44M
  • Shares Out95.14M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change1.8

RATIOS/PROFITABILITY

  • EPS (TTM)-0.51
  • P/E (TTM)-1.67
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Theratechnologies Inc

 

Content From Our Affiliates

Profile

MORE
Theratechnologies Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. The Company commercializes two medicines in human immunodeficiency viruses (HIV) and has research programs in non-alcoholic steatohepatitis (NASH), Oncology and HIV. Its medicines include Trogarzo, EGRIFTA SV, and EGRIFTA. Trogarzo (ibalizumab-uiyk) is a monoclonal antibody which binds to domain 2 of...
Dawn Svoronos
Independent Chairman of the Board
Paul Levesque
President, Chief Executive Officer, Director
Philippe Dubuc
Chief Financial Officer, Senior Vice President
Jocelyn Lafond
Vice President - Legal Affairs, Corporate Secretary
Marie-Noel Colussi
Vice President - Finance
Address
2015 Peel Street, 5Th Floor
Montreal, QC
H3A 1T8
Canada